
Resonate Bio is a biotech startup based in Vienna, Austria, focused on transforming structure-based drug design. Their proprietary hybrid AI-NMR technology generates dynamic 'movies' of drugs binding to flexible, disease-causing proteins, which current technologies can only capture as static 'photos.' This innovation unlocks the potential to drug previously 'undruggable' targets. The technology allows for high-throughput, high-resolution structural analysis in solution, applicable to all synthesized compounds. The company aims to accelerate the discovery of novel therapeutics by providing a more comprehensive understanding of protein-ligand interactions.

Resonate Bio is a biotech startup based in Vienna, Austria, focused on transforming structure-based drug design. Their proprietary hybrid AI-NMR technology generates dynamic 'movies' of drugs binding to flexible, disease-causing proteins, which current technologies can only capture as static 'photos.' This innovation unlocks the potential to drug previously 'undruggable' targets. The technology allows for high-throughput, high-resolution structural analysis in solution, applicable to all synthesized compounds. The company aims to accelerate the discovery of novel therapeutics by providing a more comprehensive understanding of protein-ligand interactions.